Novo Nordisk: news and trends

Latest articles

• Mum shares warning signs after son, 13, died from undiagnosed Type 1 diabetesmirror.co.uk · English · 11-13 15:15negative
• New Obesity Drugs Challenge Clinicians to Stay Up to Datemedscape.com · English · 11-13 15:00neutral
• تحذير أمريكي جديد بشأن أدوية أوزمبيك ومونجارو وويغوفي بسبب خطر نادر يهدد البصرakhbarona.com · Arabic · 11-13 14:30negative
• Etavopivat Submitted to FDA After 27% VOC Reduction in Phase 3 SCD Trialhcplive.com · English · 11-13 14:15neutral
• لأول مرة في تونس: شراكة علمية واسعة لاطلاق أول سجل وطني موحدة لمرضى السكري من الصنف الأول..webmanagercenter.com · Arabic · 11-13 13:30negative
• Tata Sons listing: 'Regulator's verdict not a failure of advocacy'business-standard.com · English · 11-13 13:00positive
• Grandad sues Ozempic maker Novo Nordisk claiming weight loss jab left him partially blindaol.co.uk · English · 11-13 12:45negative
• Darth Vader's lightsaber from famous 'I am your father' scene sells for nearly $5mmirror.co.uk · English · 11-13 12:45neutral
• Granddad suing Ozempic maker after claiming weight loss jab 'left him partially-blind'manchestereveningnews.co.uk · English · 11-13 12:15negative
• Novo submits etavopivat, an investigational once-daily therapy for adolescents and adults living with sickle cell disease, to the FDA and EMA for approvalprnewswire.com · English · 11-13 11:45negative
• Novo Nordisk: Novo submits etavopivat, an investigational once-daily therapy for adolescents and adults living with sickle cell disease, to the FDA and EMA for approvalfinanznachrichten.de · English · 11-13 11:30negative
• Prediction: $10,000 Invested in Viking Therapeutics Before Its Oral Phase 3 Readouts Could Be Worth This Much by 2028fool.com · English · 11-13 10:45negative
• China Bought More of the World Than It Sold in October, and the CIIE Shows Why--China Economic Neten.ce.cn · English · 11-13 09:30positive
• Grandad sues Ozempic makers after claims medication 'left him partially blind'getsurrey.co.uk · English · 11-13 09:15negative
• The little-known tech job that can earn you a six-figure salary and the companies desperate to hiredailymail.com · English · 11-13 06:15neutral
• "减肥神药"或致永久失明 "司美格鲁肽副作用"冲上热搜_光明网life.gmw.cn · Chinese · 11-13 06:15negative
• "减肥神药"或致失明：GLP-1超级周期的第一道裂缝_新浪科技_新浪网sina.com.cn · Chinese · 11-13 03:30neutral
• LifeMD (NASDAQ:LFMD) Announces Earnings Results, Beats Expectations By $0.03 EPSthemarketsdaily.com · English · 11-13 02:45neutral
• FDA Reportedly Shelves Commissioner's National Priority Voucher Programpharmacytimes.com · English · 11-13 01:30positive
• 美股盘后速递：三大股指期货上涨；科技七巨头、存储芯片股全线转涨，英伟达涨超1%，闪迪涨超2%163.com · Chinese · 11-13 01:15neutral
• 黄仁勋辞职，英伟达跌超4%；国际金价跌破3900美元/盎司丨盘前情报163.com · Chinese · 11-13 01:00neutral
• 国内首个！千亿级市场 重磅新品获批（附股） _ 东方财富网eastmoney.com · Chinese · 11-13 00:45positive
• 领先诺和！国内首款口服GLP-1减重药获批 已提前启动生产- CFi.CN 中财网cfi.net.cn · Chinese · 11-13 00:45neutral
• Utah is seeking diabetes patients' testimony to include in insulin price lawsuitkpcw.org · English · 11-13 00:15neutral
• 国内首个！千亿级市场，重磅新品获批（附股）sina.com.cn · Chinese · 11-13 00:15positive

Headlines in the original language. Translation, AI summary and contested stories arrive with AI labelling.

Related topics